Course Overview
The Comprehensive Hematology and Oncology Review Course provides an in-depth review of current standards of care, clinical guidelines and therapeutic advances.
Why Attend This Course
Designed for oncology professionals who need a comprehensive, clinically relevant update.
• Broad review of hematology and medical oncology
• Content aligned with national clinical guidelines
• Case-based sessions to support real-world decision-making
• Led by oncology clinicians and researchers
• Opportunities for peer connection and discussion
Board Exam Preparation
• Structured review of high-yield clinical topics
• Reinforcement of guideline-based treatment approaches
• Summary of key clinical trials and evolving standards of care
Participants will:
• Review diagnosis and management of solid tumors and hematologic conditions
• Analyze evolving treatment strategies and emerging therapies
• Apply evidence-based recommendations to clinical practice
Who Should Attend
• Physicians specializing in oncology or hematology
• Advanced practice providers
• Oncology nurses and pharmacists
• Residents and fellows
• Other health care professionals involved in cancer care
Registration
Registration is required. The registration deadline is October 9, 2026
To learn more about this course, click here.
Bay Auditorium
2211 Alaskan Way, Seattle, WA 98121